These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28385352)

  • 1. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
    Prague JK; Roberts RE; Comninos AN; Clarke S; Jayasena CN; Nash Z; Doyle C; Papadopoulou DA; Bloom SR; Mohideen P; Panay N; Hunter MS; Veldhuis JD; Webber LC; Huson L; Dhillo WS
    Lancet; 2017 May; 389(10081):1809-1820. PubMed ID: 28385352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin 3 receptor antagonism - the magic bullet for hot flushes?
    Prague JK; Dhillo WS
    Climacteric; 2017 Dec; 20(6):505-509. PubMed ID: 29040006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial.
    Vrselja A; Latifi A; Baber RJ; Stuckey BGA; Walker MG; Stearns V; Hickey M; Davis SR
    Lancet; 2022 Nov; 400(10364):1704-1711. PubMed ID: 36366886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Neuroendocrinology; 2019; 109(3):242-248. PubMed ID: 30504731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
    Irani J; Salomon L; Oba R; Bouchard P; Mottet N
    Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
    Speroff L; Gass M; Constantine G; Olivier S;
    Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
    Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
    Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy germ extract alleviates menopausal hot flushes: placebo-controlled double-blind trial.
    Imhof M; Gocan A; Imhof M; Schmidt M
    Eur J Clin Nutr; 2018 Jul; 72(7):961-970. PubMed ID: 29849181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.
    Lederman S; Ottery FD; Cano A; Santoro N; Shapiro M; Stute P; Thurston RC; English M; Franklin C; Lee M; Neal-Perry G
    Lancet; 2023 Apr; 401(10382):1091-1102. PubMed ID: 36924778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.
    Depypere H; Timmerman D; Donders G; Sieprath P; Ramael S; Combalbert J; Hoveyda HR; Fraser GL
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5893-5905. PubMed ID: 31415087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study.
    Winther K; Rein E; Hedman C
    Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes.
    Maclennan AH; Broadbent JL; Lester S; Moore V
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD002978. PubMed ID: 15495039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture for menopausal hot flushes.
    Dodin S; Blanchet C; Marc I; Ernst E; Wu T; Vaillancourt C; Paquette J; Maunsell E
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007410. PubMed ID: 23897589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes.
    Modi M; Dhillo WS
    Semin Reprod Med; 2019 May; 37(3):125-130. PubMed ID: 31869840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial.
    Ewies A; Ahmed I; Al-Azzawi F; Pitkin J; Gupta P; Persic M; Sahu B; Elgobashy A; Barraclough L; Woodman J; Babrah J; Bowden S; Stocken D; Billingham L; Sundar S; Rea D
    BJOG; 2021 Nov; 128(12):2024-2033. PubMed ID: 33982872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial.
    Pan Y; Meister R; Löwe B; Winkelmann A; Kaptchuk TJ; Buhling KJ; Nestoriuc Y
    Trials; 2019 Aug; 20(1):508. PubMed ID: 31420050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label placebos for menopausal hot flushes: a randomized controlled trial.
    Pan Y; Meister R; Löwe B; Kaptchuk TJ; Buhling KJ; Nestoriuc Y
    Sci Rep; 2020 Nov; 10(1):20090. PubMed ID: 33208855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol.
    Mann E; Smith M; Hellier J; Hunter MS
    BMC Cancer; 2011 Jan; 11():44. PubMed ID: 21281461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review.
    Menown SJ; Tello JA
    Adv Ther; 2021 Oct; 38(10):5025-5045. PubMed ID: 34514552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.